These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 641832)

  • 21. Analysis of anticholinesterase-induced neuromuscular transmission failure.
    Maselli RA; Leung C
    Muscle Nerve; 1993 May; 16(5):548-53. PubMed ID: 8390609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necrotic extrafusal muscle fibers of the dystrophic mutant mouse: the ultrastructure of the myoneural junction.
    Ontell M; Haller E
    Anat Rec; 1980 Aug; 197(4):397-411. PubMed ID: 7212293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the neuromuscular junction and striated muscle fiber following the administration of neostigmine methylsulfate in rats. A morphological observation (author's transl)].
    Kawabuchi M; Osame M; Watanabe S; Igata A; Kanaseki T
    Fukuoka Igaku Zasshi; 1975 Aug; 66(8):500-11. PubMed ID: 1237456
    [No Abstract]   [Full Text] [Related]  

  • 25. Postsynaptic structure may account for variations in miniature endplate current shapes along frog neuromuscular junctions.
    Fortier LP; Tremblay JP
    Synapse; 1990; 5(4):255-64. PubMed ID: 2360195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacology of the neostigmine-like facilitatory drug effect at the mammalian neuromuscular junction.
    Riker WF
    Jpn J Pharmacol; 1972; 22():Suppl22:1. PubMed ID: 4342470
    [No Abstract]   [Full Text] [Related]  

  • 27. [Investigations into neostigmine-induced inhibition of neuromuscular transmission].
    Kitajima O; Suzuki T; Fukano N; Miyake E; Saeki S; Ogawa S
    Masui; 2009 Apr; 58(4):410-5. PubMed ID: 19363999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF; Autio D; Rheuben MB; Atchison WD
    J Neurophysiol; 2002 Dec; 88(6):3243-58. PubMed ID: 12466444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neostigmine-induced end-plate proliferation in the rat. A study using supra-vital methylene blue.
    Schwartz MS; Sargeant MK; Swash M
    Neurology; 1977 Mar; 27(3):289-93. PubMed ID: 66646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin of true intranuclear inclusions in the soleplate region of rat skeletal muscle fibers following chronic daily administration of neostigmine.
    Kawabuchi M; Kanaseki T
    Fukuoka Igaku Zasshi; 1988 Jun; 79(6):440-3. PubMed ID: 2852631
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex.
    Fiekers JF
    J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission.
    Lee DC; Kim YI; Liu HH; Johns TR
    Muscle Nerve; 1983; 6(6):442-7. PubMed ID: 6312309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cholinesterase inhibitors on synaptic potentials of the frog neuromuscular junction.
    Fedorov VV
    Neurosci Behav Physiol; 1976; 7(3):201-6. PubMed ID: 1088608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neostigmine myopathy is a calcium ion-mediated myopathy initially affecting the motor end-plate.
    Kawabuchi M
    J Neuropathol Exp Neurol; 1982 May; 41(3):298-314. PubMed ID: 6804607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural studies of young and old mouse neuromuscular junctions.
    Fahim MA; Robbins N
    J Neurocytol; 1982 Aug; 11(4):641-56. PubMed ID: 7131048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR; Kim YI; Sanders DB
    J Neurol Sci; 1983 Jun; 59(3):431-40. PubMed ID: 6875609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure.
    Engel AG; Lambert EH; Santa T
    Neurology; 1973 Dec; 23(12):1273-81. PubMed ID: 4357114
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of acetylcholinesterase accelerates axon terminal withdrawal at the developing rat neuromuscular junction.
    Duxson MJ; Vrbová G
    J Neurocytol; 1985 Jun; 14(3):337-63. PubMed ID: 4045509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term administration of ambenonium chloride on motor end-plate fine structure and acetylcholine receptor in rat.
    Hazama R; Tsujihata M; Mori M; Takamori M; Mori K; Shibuya N
    J Neurol Sci; 1981 Jul; 51(1):69-79. PubMed ID: 7252521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.